Government/Legal Affairs

On November 21, the New York Department of Financial Services (DFS) announced sweeping market conduct regulations for pharmacy benefit managers (PBMs) serving health plans in the state. The DFS rule implements a landmark 2021 bill, S. 3762/A. 1396, which imposed restrictions on PBM contracts with health plans and pharmacies and established consumer protections. This action follows previous DFS rulemaking that created a broad definition of pharmacy benefit management services, required PBMs operating in the state to obtain a license, and established annual reporting requirements.

Host Fred Goldstein invites Jennifer Mathieu, Senior Vice President, Professional & Government Affairs to discuss the Prescription Digital Therapeutics Act, the Medicaid MVPs for Patient Act and other AMCP legislative priorities.

Host Fred Goldstein invites Adam Colborn, Director, Government Affairs at AMCP to discuss AMCP Federal Legislative Priorities on this second episode of a two part discussion.

Health care expert Fred Goldstein sits down with Adam Colborn, director of government affairs at AMCP, to discuss AMCP’s federal policy priorities in the 118th Congress.

AMCP welcomes the introduction of the Medicaid VBPs for Patients Act. The legislation would expand Medicaid access to novel therapies.

AMCP webinar that discussed AMCP’s 2021 Legislative and Regulatory Priority Issues and Strategies.